| NCT ID | NCT06718569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Diakonhjemmet Hospital |
| Condition | Arthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2025-11-11 |
| Primary Completion | 2027-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2025-11-11 with a primary completion date of 2027-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.
Eligibility Criteria
Inclusion Criteria: * All patients who initiate or switch biological or targeted synthetic DMARDs Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06718569 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06718569 currently recruiting?
Yes, NCT06718569 is actively recruiting participants. Contact the research team at ida.k.haugen@gmail.com for enrollment information.
Where is the NCT06718569 trial being conducted?
This trial is being conducted at Oslo, Norway.
Who is sponsoring the NCT06718569 clinical trial?
NCT06718569 is sponsored by Diakonhjemmet Hospital. The trial plans to enroll 350 participants.